Skip to content

Opening book details…

About this Medicine article

Topotecan, a topoisomerase I inhibitor, is active in the treatment of myelodysplastic syndrome and chronic myelomonocytic leukemia by Beran, M; Kantarjian, H; O'Brien, S; Koller, C; al-Bitar, M; Arbuck, S; Pierce, S; Moore, M; Abbruzzese, JL; Andreeff, M; Keating, M; Estey, E is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Beran, M; Kantarjian, H; O'Brien, S; Koller, C; al-Bitar, M; Arbuck, S; Pierce, S; Moore, M; Abbruzzese, JL; Andreeff, M; Keating, M; Estey, E
Publisher
American Society of Hematology (ISSN 0006-4971)
Published
1996
Field
Medicine (Health Sciences)

More by Beran, M; Kantarjian, H; O'Brien, S; Koller, C; al-Bitar, M; Arbuck, S; Pierce, S; Moore, M; Abbruzzese, JL; Andreeff, M; Keating, M; Estey, E

Browse all works by Beran, M; Kantarjian, H; O'Brien, S; Koller, C; al-Bitar, M; Arbuck, S; Pierce, S; Moore, M; Abbruzzese, JL; Andreeff, M; Keating, M; Estey, E